#news #biotech Lilly’s Skyrizi rival hits goal in ulcerative colitis phase 3, as it ups the ante against AbbVie

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Lilly’s Skyrizi rival hits goal in ulcerative colitis phase 3, as it ups the ante against AbbVie .Lilly’s Skyrizi rival hits goal in ulcerative colitis phase 3, as it ups the ante against AbbVie
ntaylor
Tue, 03/16/2021 – 09:08

from FierceBiotech: Biotech https://ift.tt/2OTPrSi